12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
週二盤中交易時段，12只醫療保健類股走勢
Gainers
獲勝者
- Nexalin Technology (NASDAQ:NXL) stock increased by 47.9% to $2.81 during Tuesday's regular session. The market value of their outstanding shares is at $20.4 million.
- MSP Recovery (NASDAQ:LIFW) shares moved upwards by 33.26% to $0.89. The market value of their outstanding shares is at $13.1 million.
- Aditxt (NASDAQ:ADTX) shares increased by 19.09% to $3.79. The market value of their outstanding shares is at $6.3 million.
- Q32 Bio (NASDAQ:QTTB) shares increased by 17.69% to $21.18. The company's market cap stands at $252.7 million.
- Evaxion Biotech (NASDAQ:EVAX) stock rose 16.4% to $3.76. The market value of their outstanding shares is at $18.0 million. As per the news, the Q4 earnings report came out 4 days ago.
- Concord Medical Services (NYSE:CCM) shares rose 15.38% to $0.6. The market value of their outstanding shares is at $26.0 million.
- Nexalin Technology（納斯達克股票代碼：NXL）股價在週二的例行交易中上漲了47.9％，至2.81美元。他們已發行股票的市值爲2,040萬美元。
- MSP Recovery（納斯達克股票代碼：LIFW）股價上漲33.26％，至0.89美元。他們已發行股票的市值爲1310萬美元。
- Aditxt（納斯達克股票代碼：ADTX）股價上漲19.09％，至3.79美元。他們已發行股票的市值爲630萬美元。
- 第三季度生物（納斯達克股票代碼：QTTB）股價上漲17.69％，至21.18美元。該公司的市值爲2.527億美元。
- Evaxion Biotech（納斯達克股票代碼：EVAX）股價上漲16.4％，至3.76美元。他們已發行股票的市值爲1,800萬美元。根據新聞，第四季度收益報告是在4天前發佈的。
- 康科德醫療服務（紐約證券交易所代碼：CCM）股價上漲15.38％，至0.6美元。他們已發行股票的市值爲2600萬美元。
Losers
失敗者
- Acorda Therapeutics (NASDAQ:ACOR) stock decreased by 75.8% to $3.26 during Tuesday's regular session. The company's market cap stands at $4.0 million. The company's, Q4 earnings came out yesterday.
- Gritstone Bio (NASDAQ:GRTS) stock declined by 48.94% to $1.2. The company's market cap stands at $117.6 million.
- Orgenesis (NASDAQ:ORGS) stock fell 40.61% to $0.34. The company's market cap stands at $11.7 million.
- Verve Therapeutics (NASDAQ:VERV) shares decreased by 36.28% to $8.15. The company's market cap stands at $681.4 million.
- Yield10 Bioscience (NASDAQ:YTEN) shares decreased by 25.53% to $0.29. The company's market cap stands at $3.4 million. The company's, Q4 earnings came out yesterday.
- GRI Bio (NASDAQ:GRI) stock decreased by 24.66% to $0.56.
- 在週二的例會中，Acorda Therapeutics（納斯達克股票代碼：ACOR）的股價下跌了75.8％，至3.26美元。該公司的市值爲400萬美元。該公司昨天公佈了第四季度的收益。
- Gritstone Bio（納斯達克股票代碼：GRTS）股價下跌48.94％，至1.2美元。該公司的市值爲1.176億美元。
- Orgenesis（納斯達克股票代碼：ORGS）股價下跌40.61％，至0.34美元。該公司的市值爲1170萬美元。
- Verve Therapeutics（納斯達克股票代碼：VERV）股價下跌36.28％，至8.15美元。該公司的市值爲6.814億美元。
- Yield10 Bioscience（納斯達克股票代碼：YTEN）股價下跌25.53％，至0.29美元。該公司的市值爲340萬美元。該公司昨天公佈了第四季度的收益。
- GRI Bio（納斯達克股票代碼：GRI）股價下跌24.66％，至0.56美元。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。